JPS63152992A - Antibiotic substance tan-876 and production thereof - Google Patents
Antibiotic substance tan-876 and production thereofInfo
- Publication number
- JPS63152992A JPS63152992A JP15678687A JP15678687A JPS63152992A JP S63152992 A JPS63152992 A JP S63152992A JP 15678687 A JP15678687 A JP 15678687A JP 15678687 A JP15678687 A JP 15678687A JP S63152992 A JPS63152992 A JP S63152992A
- Authority
- JP
- Japan
- Prior art keywords
- tan
- antibiotic
- streptomyces
- medium
- antibiotic substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003115 biocidal effect Effects 0.000 claims abstract description 30
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 241000187747 Streptomyces Species 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims description 4
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 8
- 229920002472 Starch Polymers 0.000 abstract description 7
- 239000008107 starch Substances 0.000 abstract description 7
- 235000019698 starch Nutrition 0.000 abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 5
- 241000233866 Fungi Species 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- 244000068988 Glycine max Species 0.000 abstract description 4
- 235000010469 Glycine max Nutrition 0.000 abstract description 4
- 239000001888 Peptone Substances 0.000 abstract description 4
- 108010080698 Peptones Proteins 0.000 abstract description 4
- 238000004587 chromatography analysis Methods 0.000 abstract description 4
- 239000000706 filtrate Substances 0.000 abstract description 4
- 235000013312 flour Nutrition 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 235000019319 peptone Nutrition 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003905 agrochemical Substances 0.000 abstract description 3
- 229910052799 carbon Inorganic materials 0.000 abstract description 3
- 238000012258 culturing Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000002609 medium Substances 0.000 description 26
- 229920001817 Agar Polymers 0.000 description 15
- OMHHHZRYNBZJEK-UHFFFAOYSA-N O=C1C2=C(O)C(CC)=CC(Cl)=C2OC2=C1C(Cl)=C(Cl)N2 Chemical compound O=C1C2=C(O)C(CC)=CC(Cl)=C2OC2=C1C(Cl)=C(Cl)N2 OMHHHZRYNBZJEK-UHFFFAOYSA-N 0.000 description 15
- 239000008272 agar Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000003242 anti bacterial agent Substances 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 241000219198 Brassica Species 0.000 description 4
- 235000003351 Brassica cretica Nutrition 0.000 description 4
- 235000003343 Brassica rupestris Nutrition 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 4
- 235000010460 mustard Nutrition 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 241000142898 Streptomyces neyagawaensis Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 244000223014 Syzygium aromaticum Species 0.000 description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 235000019646 color tone Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- ZGZVMKCZHDIFQA-UHFFFAOYSA-N cervicarcin Chemical compound CC1OC1C(=O)C1(O)C(O)C2(C(O)C=3C(=CC=CC=3O)C3=O)OC23C(O)C1C ZGZVMKCZHDIFQA-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- BBBFYZOJHSYQMW-LGDQNDJISA-N (2s)-2,4-diamino-4-oxobutanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O BBBFYZOJHSYQMW-LGDQNDJISA-N 0.000 description 1
- UQZSVIGPZAULMV-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)[C@@H](N)CC(N)=O UQZSVIGPZAULMV-DKWTVANSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- -1 Dragendorff Chemical compound 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 244000039154 Erica Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241000515012 Micrococcus flavus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- ZCJHPTKRISJQTN-UHFFFAOYSA-N Nanaomycin Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1C(C)OC(CC(O)=O)C2 ZCJHPTKRISJQTN-UHFFFAOYSA-N 0.000 description 1
- 229930191665 Nanaomycin Natural products 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001161107 Sphyraena ensis Species 0.000 description 1
- 229920000535 Tan II Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- JYVLIDXNZAXMDK-UHFFFAOYSA-N methyl propyl carbinol Natural products CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は細菌および真菌感染症の治療剤として有用な新
規抗生物質TAN−876(以下、rTAN−876J
と略称することもある。)およびその製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel antibiotic TAN-876 (rTAN-876J) useful as a therapeutic agent for bacterial and fungal infections.
It is sometimes abbreviated as. ) and its manufacturing method.
従来の技術
本抗生物質に比較的類似の抗生物質としてセルヒカルシ
ン[cervicarcin−ジャーナル・オブーアメ
リカン・ケミカル・ソサエティー(JOurnal o
fAmerican Chemical 5oci
ety)、86Q、4507頁(1964年)]あるい
はナナオマインン[Nanaomycin−ツヤーナル
―オブψアンテイヒオテイクス(Journal o
f Antibiotics)、28巻、868頁(
1975年)]などが挙げられるが、これらはハロゲン
を含まない化合物であり、本抗生物質とは異なる。Prior Art An antibiotic relatively similar to the present antibiotic is cervicarcin [Journal of the American Chemical Society].
fAmerican Chemical 5oci
ety), 86Q, p. 4507 (1964)] or Nanaomycin [Journal of Antibiotics].
f Antibiotics), volume 28, page 868 (
(1975)], but these are halogen-free compounds and are different from the present antibiotic.
発明が解決しようとする問題点
細菌によって惹起される疾病は抗生物質投与による治療
法の発達によってかなり克服されている。Problems to be Solved by the Invention Diseases caused by bacteria have been largely overcome by the development of therapeutic methods by administering antibiotics.
しかし、従来の抗生物質を長期または大量に投与するこ
とによる起因閑の変化および耐性菌の出現などによる疾
患の増大あるいは免疫力低下による真菌症の増加などは
現在の感染症治療分野で大きな問題となっている。この
問題を克服するために、当分野では、常に新規骨格を有
し、優れた生物活性を示す抗生物質、あるいはそれらを
合成するための中間原料が求められている。However, the increase in diseases caused by long-term or large-dose administration of conventional antibiotics and the appearance of resistant bacteria, as well as the increase in fungal diseases due to weakened immunity, are major problems in the current field of infectious disease treatment. It has become. To overcome this problem, the field is constantly looking for antibiotics that have novel skeletons and exhibit excellent biological activity, or intermediate raw materials for synthesizing them.
問題点を解決するための手段
本発明者らはかかる現状に鑑みて、新たな観点から、細
菌感染症の治療薬の研究を重ねた結果、土壌から分離さ
れた多数の微生物中、ある種の微生物が新規抗生物質を
産生ずること、該微生物がストレプトミセス属に属する
こと、該微生物を適宜の培地に培養することによって、
耐性菌を含むダラム陽性、陰性菌、抗酸性菌などの細菌
類および医真菌、酵母、植物病原性菌な−どの真菌類に
対して抗菌力を示す抗生物質を培地中に蓄積しうろこと
を知り、この抗生物質を単離し、その物理化学的および
生物学的諸性質から、当該抗生物質が新規抗生物質であ
ることを確かめ、これを抗生物質TAN−876と称す
ることとした。抗生物質TAN−876は2成分から成
り、これらをそれぞれTAN−876AおよびBと称す
ることとした。 本発明者らは、これらの知見に基づい
て、さらに研究した結果、本発明を完成した。Means for Solving the Problems In view of the current situation, the present inventors conducted repeated research on therapeutic agents for bacterial infections from a new perspective, and found that among the large number of microorganisms isolated from soil, certain The microorganism produces a new antibiotic, the microorganism belongs to the genus Streptomyces, and the microorganism is cultured in an appropriate medium.
Antibiotics that exhibit antibacterial activity against bacteria such as Durham-positive bacteria, acid-fast bacteria, including resistant bacteria, and fungi such as medical fungi, yeast, and plant pathogenic bacteria are accumulated in the culture medium. We isolated this antibiotic and confirmed that it was a new antibiotic based on its physicochemical and biological properties, and decided to name it antibiotic TAN-876. Antibiotic TAN-876 consists of two components, which are referred to as TAN-876A and B, respectively. The present inventors completed the present invention as a result of further research based on these findings.
すなわち本発明は、(1)抗生物質TAN−876また
はその塩、および(2)ストレプトミセス属に属する抗
生物質TAN−876生産菌を培地に培養し、培養物中
に抗生物質TAN−876を生成蓄晴せしめ、これを採
取することを特徴とする抗生物質TAN−876の製造
法に関する。That is, the present invention provides for culturing (1) antibiotic TAN-876 or a salt thereof, and (2) antibiotic TAN-876-producing bacteria belonging to the genus Streptomyces in a medium, and producing antibiotic TAN-876 in the culture. The present invention relates to a method for producing antibiotic TAN-876, which is characterized by accumulating and collecting the precipitate.
本発明方法で使用される抗生物質TAN−876を生産
する菌としては、ストレプトミセス(S Lrepto
s+yces)属に属し、抗生物質TAN−876を産
生ずる能力を有する微生物であればいずれのものでもよ
い。その例としては、土壌より分離されたC−7089
9殊が挙げられ、本菌株の菌学的性質は下記のとおりで
ある。なお、各種培地上の性質はとくに指示しない限り
、28℃で14日間培養し、常法に従って観察したもの
であり、色調はカラー・ハーモニー・マニュアル(Co
lorHarmony Manual)第4版[コン
テイナー−コーポレーション拳オブ・アメリカ(Con
tainerCorporation or Am
erica)、1958年発行コによった。The bacterium that produces the antibiotic TAN-876 used in the method of the present invention is Streptomyces (S Lrepto
Any microorganism may be used as long as it belongs to the genus S+yces and has the ability to produce the antibiotic TAN-876. An example is C-7089 isolated from soil.
The mycological properties of this strain are as follows. In addition, unless otherwise specified, the properties on the various media are those obtained by culturing at 28°C for 14 days and observing according to conventional methods.The color tones are based on the Color Harmony Manual (Co
lorHarmony Manual) 4th Edition [Container - Corporation Fist of America (Container
tainerCorporation or Am
Erica), published in 1958.
!、形態
気菌糸および胞子の形成は、イースト・麦芽寒天、澱粉
無機塩寒天、グリセロール・アスパラギン寒天等の培地
上で豊富に認められる。気菌糸の分枝は単純分枝で、車
軸分枝は認められず、その先端には、螺旋状に胞子の連
鎖か認められる。菌核、胞子のう等の特殊な構造は認め
られない。電子顕微鏡による観察では、胞子の表面は平
滑であり、胞子の形は、球形、卵形ないし短円筒形であ
り、それらの大きさは0.8〜1.2xo、8〜1゜0
ミクロンで、通常20個以上連鎖する。! Formation of aerial hyphae and spores is abundantly observed on media such as yeast/malt agar, starch inorganic salt agar, and glycerol/asparagine agar. The branches of the aerial hyphae are simple branches, no axle branches are observed, and a spiral chain of spores is observed at the tip. No special structures such as sclerotia or sporangia are observed. When observed using an electron microscope, the surface of the spores is smooth, and the shape of the spores is spherical, oval, or short cylindrical, and their sizes are 0.8 to 1.2xo, 8 to 1°0.
Microns, usually 20 or more in a chain.
2、各種分類培地上の性!(28℃、14日間培養)
1)蔗糖・硝酸塩寒天培地
生育;中程度、ライト・イエロー(11/2ea)〜ダ
スティー・イエロー(z 1/2gc)気菌糸:貧弱な
いし中程度、白色
裏面の色:バター・イエロー(l l/2ga)〜バン
ブー(2gc)
可溶性色素;なし
2)イースト・麦芽寒天培地
生育:中程度ないし良好、クローブ・ブラウン(apl
)
気菌糸:豊富、シルバー・グレー(3fe)裏面の色:
クローブ・ブラウン(3pl)可溶性色素:なし
3)オート・ミール寒天培地
生育:中程度、ライト・アイポリ−(2ca)気菌糸:
中程度、アドーブ・ブラウン(31g)裏面の色ニライ
ト・スパイス・ブラウン(41g)
可溶性色素:褐色〜黄褐色
4)澱粉無機塩寒天培地
生育:中程度マスタード・ブラウン(2ni)気菌糸:
豊富、ナヂュラル(2dC)〜シルバー・グレー(3「
e)
裏面の色:マスタード・ブラウン(2ni)〜コバート
・ブラウン(2nl)
可溶性色素:なし
5)グリセロール・アスパラギン寒天培地生育:中程度
、ライト・マスタード・タン(2ie)
気菌糸:豊富、ナチュラル(2dc)〜ナチュラル(3
dc)〜シルバー・グレー
(3fe)
裏面の色:バンブー(2gc)〜マスタード・タン(2
1g)
可溶性色素:なし
6)グルコース・アスパラギン寒天培地生育:中程度、
無色
気菌糸:中程度、ソルバー・グレー(3re)〜アッシ
ズ(5rc)
裏面の色:無色〜ライト・マスタード・タン(2ie)
可溶性色素:なし
7)ペプトン・イースト・鉄寒天培地
生育:中程度、しわを生ずる、バイジエ・ブラウン(3
ig)
気菌糸二着生せず
裏面の色:バイジエ・ブラウン(3ig)可溶性色素:
褐色〜クローブ・ブラウン(3ni)
8)ヂロシン寒天培地
生育:中程度、褐色〜暗褐色
気菌糸:貧弱、白色
裏面の色:褐色〜暗褐色
可溶性色素:淡黄褐色
9)カルシウム・マレイド寒天培地
生育:貧弱、無色
気菌糸二着生せず
裏面の色:無色〜クリーム(l I/2ca)可溶性色
素:なし
3、生理的性質
1)生育温度範囲: 12〜40℃
至適温度範囲:22〜37℃
2)ゼラチンの液化: 陰性
3)澱粉の加水分解: 陽性
4)ミルクのペプトン化 陰性
5)ミルクの凝固: 陰性
6)硝酸塩の還元: 陽性
7)メラニン様色素の生成:陽性
8)炭素源の利用性
D−ソルビトール − ンユークロース −l−イノ
シトール + ラクトース +D−マンニトール
+ ラフィノース +D−キンロース +
トレハロース +L−アラビノース + マンノー
ス +D−ガラクトース + 可溶性澱粉
十り−グルコース + グリセロール +D−フ
ラクトース + メリビオース +ラムノース
+ マルトース +アドニトール +
エスクリン −エリスリトール − サリシ
ン +ズルチトール − イヌリン
−セルロース − リボース +ソル
ボース − 無添加 −基礎培地:ブ
リドハムとゴツトリーブ寒天培地4、全菌体の加水分解
物中のジアミノピメリン酸の分析[長谷用徹ら、ジャー
ナル・オブ・ゼネラル・アプライド・マイクロバイオロ
ジー(Journal or General
Applied Microbiology)、λy
、319(1983)の方法]LL−2.6−ツアミノ
ビメリン酸が認められた。2. Sex on various classification media! (Culture at 28°C for 14 days) 1) Growth on sucrose/nitrate agar medium: Moderate, light yellow (11/2ea) to dusty yellow (z 1/2gc) Aerial mycelium: poor to moderate, white underside color : Butter Yellow (l l/2ga) ~ Bamboo (2gc) Soluble pigment: None 2) Yeast/malt agar growth: Moderate to good, Clove brown (apl)
) Aerial mycelium: Abundant, silver/gray (3fe) Back color:
Clove Brown (3 pl) Soluble pigment: None 3) Oat Meal Agar Medium Growth: Medium, Light Ipoly- (2 ca) Aerial Mycelium:
Medium, adobe brown (31g) Underside color Nirite Spice Brown (41g) Soluble pigment: brown to tan 4) Starch inorganic salt agar growth: Medium Mustard brown (2ni) Aerial mycelium:
Rich, natural (2dC) to silver gray (3"
e) Back side color: Mustard brown (2ni) ~ Covert brown (2nl) Soluble pigment: None 5) Glycerol-asparagine agar growth: Medium, light mustard tan (2ie) Aerial mycelium: Abundant, natural ( 2dc) ~ Natural (3
dc) ~ Silver Gray (3fe) Back color: Bamboo (2gc) ~ Mustard Tan (2
1g) Soluble dye: None 6) Glucose-asparagine agar medium Growth: Moderate;
Colorless aerial mycelium: medium, solver gray (3re) ~ Ashes (5rc) Underside color: colorless ~ light mustard tan (2ie) Soluble pigment: none 7) Peptone yeast iron agar medium growth: medium, Byjie Brown (3), which causes wrinkles
ig) Color of underside without double epiphyte aerial mycelium: Vizier brown (3ig) Soluble pigment:
Brown to clove brown (3ni) 8) Dirosine agar medium growth: Moderate, brown to dark brown Aerial hyphae: Poor, white Underside color: brown to dark brown Soluble pigment: Light yellowish brown 9) Calcium maleide agar medium growth : Poor, colorless, no epiphyte mycelia Underside color: Colorless to cream (l I/2ca) Soluble pigment: None 3, Physiological properties 1) Growth temperature range: 12-40℃ Optimum temperature range: 22- 37℃ 2) Liquefaction of gelatin: Negative 3) Hydrolysis of starch: Positive 4) Peptonization of milk Negative 5) Coagulation of milk: Negative 6) Reduction of nitrate: Positive 7) Formation of melanin-like pigment: Positive 8) Carbon Source availability D-Sorbitol - Neuclose - l-Inositol + Lactose + D-Mannitol + Raffinose + D-Kinlose +
Trehalose + L-arabinose + Mannose + D-galactose + Soluble starch
Ten-glucose + glycerol + D-fructose + melibiose + rhamnose
+ Maltose + Adonitol +
Aesculin - Erythritol - Salicin + Dulcitol - Inulin
- Cellulose - Ribose + Sorbose - No additives - Basal medium: Bridham and Gottlieb agar 4, analysis of diaminopimelic acid in whole bacterial cell hydrolyzate [Toru Hase et al., Journal of General Applied Microbiology (Journal or General
Applied Microbiology), λy
, 319 (1983)] LL-2,6-tzaminobimelic acid was observed.
以上の菌学的性質を要約すると、C−70899株は、
気菌糸先端が螺旋状を呈し、胞子表面ば下情である。発
育色調は、淡黄色、黄褐色ないし褐色を呈し、気菌糸は
灰色系である。なお、メラニン様可溶性色素を生成する
。また、LL−ジアミノピメリン酸が菌体より検出され
ることにより、本菌は細胞壁タイプ1に帰属する。以上
の性質をらとに、ニス・ニー・ワックスマン著、ノ・ア
クチノミセテス(T’he ActinomyccL
es)第2巻、ザ・ウィリアムス・アンド・ウイルキン
ス・カンパニー発行、1961年、およびアール・イー
・ブッファナン・アンド・エヌ・イー・ギボンス編、バ
ーノーズ、マニュアル・オブ・デタミネーティブ・パク
テリオロジ−(Bergey’s Manual
ofDeLern+1native BacLeri
ology)第8版、1974年に従って菌種の検索を
行った。その結果、上記C−70899株に比較的近縁
な菌種として、ストレプトミセス・レジストミシフィカ
ス(Streptomyces resistomy
cificus)およびストレプトミセス・ネヤガワエ
ンシス(S treptomycesneyagawa
ensis)が挙げられる。これら2菌種についてさら
に詳細な検討を行うため、ストレプトミセス・レジスト
ミシフィカスIFO12814およびストレプトミセス
・ネヤガワエンシスIFO13477について調べた結
果、これら両菌種は、下記の点でC−70899株と相
違することが認められた。To summarize the above mycological properties, C-70899 strain is
The tip of the aerial hyphae has a spiral shape, and the spore surface is rough. The color tone of growth is pale yellow, yellowish brown or brown, and the aerial mycelium is grayish. In addition, melanin-like soluble pigment is produced. Furthermore, since LL-diaminopimelic acid was detected in the bacterial cells, this bacteria belongs to cell wall type 1. Based on the above properties, T'he Actinomycetes, written by Nis ny Waxman,
es) Volume 2, The Williams & Wilkins Company, 1961, and R. E. Bouffanin and N. E. Gibbons, eds., Vernose, Manual of Determinative Pacteriology (Bergey' s Manual
ofDeLearn+1native BacLeri
Bacterial species were searched according to the 8th edition (1974). As a result, Streptomyces resistomicus (Streptomyces resistomyces) was found to be a bacterial species relatively related to the C-70899 strain.
cificus) and Streptomyces neyagawaensis (S.
ensis). In order to conduct a more detailed study on these two bacterial species, we investigated Streptomyces resistomicus IFO12814 and Streptomyces neyagawaensis IFO13477, and found that these two bacterial species differ from strain C-70899 in the following points. Admitted.
ストレプトミセス・レジストミシフィカス:イースト・
麦芽寒天培地上で気菌糸は開放形の螺旋も認められるが
、全般に不完全な螺旋あるいは錠状の形態を呈する。ま
た、その色調は淡桃茶色(フレッシュ・ピンク、4 c
a)ないし淡黄茶色(ファウン、4 ig)である。シ
ュークロースを利用する。Streptomyces resistomicus: yeast
Although open spirals of aerial hyphae are observed on malt agar medium, they generally exhibit an incomplete spiral or tablet-like morphology. In addition, its color tone is light pink (fresh pink, 4 c
a) to light yellowish brown (faun, 4ig). Use sucrose.
ストレプトミセス・ネヤガワエンシス:イースト・麦芽
寒天培地上で、気菌糸の着生は、一般に貧弱であり、そ
の色調は砂色(サンド、3 cb)である。胞子の形態
は長楕円体である。シュークロースを利用する。Streptomyces neyagawaensis: On yeast malt agar medium, aerial mycelial settlement is generally poor and its color is sandy (3 cb). The morphology of the spores is oblong. Use sucrose.
以上のとおり、現時点ではC−70899株と近縁関係
にある既知菌種は認められていない。As mentioned above, no known bacterial species closely related to the C-70899 strain has been recognized at this time.
従って、C−70899株を新菌種と認め、ストレプト
ミセス・ニス・ピーC−70899と命名した。Therefore, strain C-70899 was recognized as a new bacterial species and named Streptomyces nis p. C-70899.
C−70899株は昭和61年5月29日に財団法人発
酵研究所(IFO)に受託番号IFO14509として
、また本微生物は昭和61年6月13日に通商産業省工
業技術院微生物工業技術研究所(Flll)に受託番号
FERM P−8807としてそれぞれ寄託されている
。The C-70899 strain was deposited with the Fermentation Research Institute (IFO) on May 29, 1985 under the accession number IFO14509, and this microorganism was deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry on June 13, 1986. (Fllll) under accession number FERM P-8807.
ストレプトミセス属に属する抗生物質TAN−876の
生産菌は、他のストレプトミセス属の場合と同様に、そ
の性状が変化しやすく、たとえば紫外線、エックス線、
放射線、人口変異剤などを用いる人口的変異手段で容易
に変異しうるちのであり、この様な変異株であっても抗
生物質TAN−876の生産能を有するものは、すべて
本発明の方法に使用することが出来る。The bacteria that produces the antibiotic TAN-876, which belongs to the genus Streptomyces, is susceptible to changes in its properties, such as exposure to ultraviolet rays,
They are easily mutated by artificial mutagenesis methods using radiation, artificial mutagens, etc., and even such mutant strains that have the ability to produce the antibiotic TAN-876 can be used in the method of the present invention. It can be used.
本発明の方法において、抗生物質TAN−876生産菌
が培養されろ培地は、液状でも固体状でもよいが、液状
の培地がより便宜的に用いられ、また表面培養、振盪培
養法によってもよいが、深部培養方法がより有利に用い
られる。培地中には抗生物質TAN=876生産菌が同
化し得ろ炭素 。In the method of the present invention, the medium in which the antibiotic TAN-876-producing bacteria is cultured may be either liquid or solid, but a liquid medium is more conveniently used, and surface culture or shaking culture may also be used. , deep culture methods are more advantageously used. Antibiotic TAN=876 producing bacteria can assimilate carbon into the medium.
源たとえば澱粉、グルコース、デキストリン、グリセリ
ン、ンユークロース、n−パラフィンおよびアルコール
類(例、メタノール)など、窒素源としては、たとえば
有機窒素源としてコーン・スチーブ・リカー、大豆粉、
綿実粉、ペプトン、肉エキスなど、無機窒素源としては
塩化アンモニウム、硫酸アンモニウム、硝酸アンモニウ
ムおよび尿素などを使用し得る。その他、必要に応じて
無機塩類たとえばナトリウム、カリウム、マグネシウム
または燐を含む塩類、重金属塩類たとえば鉄、マンガン
、亜鉛、コバルト、銅、ニッケルなどの塩類、消泡剤た
とえば大豆油、ラード油、チキン浦、シリコン油、アク
トコール(武田薬品工業株式会社製)などを適宜添加し
ても良い。液体培養に際しては、培地のpHは中性付近
、特にpH約6〜8か好ましい。培養温度は約24℃〜
30°C1培養時間は約48〜!20時間が好ましい。Sources such as starch, glucose, dextrin, glycerin, euclose, n-paraffin and alcohols (e.g. methanol); nitrogen sources such as organic nitrogen sources such as corn stew liquor, soybean flour;
Inorganic nitrogen sources such as cottonseed flour, peptone, meat extract, etc. may be used such as ammonium chloride, ammonium sulfate, ammonium nitrate and urea. In addition, as necessary, inorganic salts such as salts containing sodium, potassium, magnesium or phosphorus, heavy metal salts such as iron, manganese, zinc, cobalt, copper and nickel salts, antifoaming agents such as soybean oil, lard oil, chicken porridge, etc. , silicone oil, Actocol (manufactured by Takeda Pharmaceutical Company Limited), etc. may be added as appropriate. In liquid culture, the pH of the medium is preferably around neutral, particularly around pH 6 to 8. Culture temperature is approximately 24℃ ~
The incubation time at 30°C is approximately 48~! 20 hours is preferred.
培養の経過にとらなって培養液中に生産される抗生物質
TAN−876の力価はミクロコツカス、 ・フラブス
IFO3242を被検菌とする寒天希釈法あるいはペー
パーディスク法の常法に従って走用される。通常、約3
〜4日間の培養で抗生物質TAN−876の生産量は最
高に達する。The titer of the antibiotic TAN-876 produced in the culture solution over the course of the culture is tested according to the conventional method of agar dilution method or paper disc method using Micrococcus flavus IFO3242 as the test bacteria. Usually about 3
The production of antibiotic TAN-876 reaches its maximum after ~4 days of culture.
培養物から目的とする抗生物質TAN−876を採取す
るには、微生物の生産する代謝物をその微生物の培養物
から採取するのに通常使用されろ分離手段が適宜利用さ
れる。たとえば’l’ A N −876は酸性脂溶性
の性質を示し、菌体および濾液中に含まれるので、培養
液に水とlQ和しないfTkjt溶媒たとえばクロロホ
ルム、酢酸エチル、メチルイソブヂルケトンあるいはブ
タノールなどを加え、TAN−876を抽出する。抽出
液を水で洗浄後、有機溶媒層を濃縮する。In order to collect the target antibiotic TAN-876 from the culture, separation means that are normally used to collect metabolites produced by microorganisms from the culture of the microorganisms are appropriately utilized. For example, 'l' AN-876 exhibits acidic and fat-soluble properties and is contained in bacterial cells and filtrate, so solvents that do not mix with water such as chloroform, ethyl acetate, methyl isobutyl ketone, or butanol are added to the culture solution. etc. to extract TAN-876. After washing the extract with water, the organic solvent layer is concentrated.
TAN−876AおよびBを含む濃縮物は、吸着、分配
あるいは分子ふるいの性質を利用したクロマトグラフィ
ーによって、さらに精製分別される。すなわち、濃縮物
を適宜の担体に接触させて有効成分を吸着u゛シめ、次
いで、適宜の溶媒で有効成分を脱離仕しめ、分別採取す
る手段が有利に利用される。担体としてはシリカゲル、
結晶セルロース、吸着性樹脂たとえばダイヤイオンHP
−20(三菱化成工業株式会社製)、アンバーライト
XAD−II(ローム・アンド・ハース社L 米国)、
セファデックスL)I−20(ファルマンア・ファイン
ケミカルズ社製、スエーデン)などが用いられる。溶出
溶媒は担体の種類によって異なるが、たとえばn−ヘキ
サン、トルエン、クロロホルム、ジクロロメタン、酢酸
エチル、アセトン、アルコール類、ピリジン、酢酸、水
あるいはこれらの混合溶媒を適宜組み合わせて用いられ
る。T A N−876を含む溶出液は濃縮乾固され、
適当な溶媒たとえばヘキサン、ジエチルエーテル、トル
エン、酢酸エチルあるいはクロロホルムなどから結晶化
あるいは濃縮乾固物に石油エーテルまたはヘキサンなど
を加えて粉末化される。The concentrate containing TAN-876A and B is further purified and fractionated by adsorption, distribution, or chromatography utilizing the properties of molecular sieves. That is, a method is advantageously used in which the concentrate is brought into contact with a suitable carrier to adsorb the active ingredient, and then the active ingredient is desorbed using a suitable solvent and then separated and collected. Silica gel as a carrier,
Crystalline cellulose, adsorbent resins such as Diaion HP
-20 (manufactured by Mitsubishi Chemical Industries, Ltd.), Amberlight XAD-II (Rohm & Haas L, USA),
Sephadex L) I-20 (manufactured by Farman Fine Chemicals, Sweden) and the like are used. The elution solvent varies depending on the type of carrier, but for example, n-hexane, toluene, chloroform, dichloromethane, ethyl acetate, acetone, alcohols, pyridine, acetic acid, water, or a mixed solvent thereof may be used in an appropriate combination. The eluate containing TAN-876 was concentrated to dryness,
It is crystallized from a suitable solvent such as hexane, diethyl ether, toluene, ethyl acetate, or chloroform, or is powdered by adding petroleum ether or hexane to the concentrated dry product.
上記のクロマトグラフィーによってら未だA、Bか分離
されない場合、これらを単離するために分取用逆相系高
速液体クロマトグラフィー(■■PLC)が有利に用い
られろ。用いられろ担体としては、たとえばTSKゲル
(東洋台JJ!社製、日本)、YMCゲル(山村化学研
究新製、日本)などが挙げられ、移動相としてはアセト
ニトリルあるいはメタノールなどと緩衝液などとの混合
液が用いられろ。If A and B are still not separated by the above chromatography, preparative reverse phase high performance liquid chromatography (■■PLC) may be advantageously used to isolate them. Examples of carriers that can be used include TSK gel (manufactured by Toyodai JJ! Co., Ltd., Japan), YMC gel (manufactured by Yamamura Kagaku Kenkyushin Co., Ltd., Japan), and mobile phases such as acetonitrile or methanol and a buffer solution. A mixture of these should be used.
なお、TAN−876AおよびBはアルカリ性溶液中の
陽イオンたとえば炭酸ナトリウム、炭酸カリウム溶液中
のナトリウムイオン、カリウムイオンなどと反応して塩
を形成する。これらの塩の精製は吸着性クロマトグラフ
ィーたとえば担体としてダイヤイオンI P −20な
どを用いたクロマトグラフィーで常法により行なわれる
。Note that TAN-876A and B react with cations in alkaline solutions, such as sodium carbonate and sodium ions and potassium ions in potassium carbonate solutions, to form salts. Purification of these salts is carried out in a conventional manner by adsorption chromatography, for example chromatography using Diaion IP-20 as a carrier.
後記の実施例1で得られた抗生物質TAN−876Aお
上びBの物理化学的性状はつぎの通りである。The physicochemical properties of antibiotics TAN-876A and B obtained in Example 1 described below are as follows.
TAN−876A
(1)外観;微黄色固体
(2)融点、>300°C(分解)
(3)分子量測定値+(El−MS法による)331(
M”)
(4)元素分析値(%);
実測値:C:47.48、If:2.83、N:4.4
9、C&:32.57
計算値・C:46.95、H:2.42、N・4.21
゜CI2:31.98、O:14.43
(5)分子式: C13H8NCC303(6)紫外部
吸収(UV)スペクトル (添付の第1図参照)
メタノール中(第1図中、実線で示す。)λmax 2
42±3nm(E’%−980±100)c2
298±3nm(E’%=308±50)lCj!
360±3nm(E1%−318±50)cx
メタノール: INt(CQ(9:I)中(第1図中
、破線で示す)
λmax 247±3nm(E1%−1+34土100
)IC肩
357±3nm(E’%−332±50)cx
メタノール: IN Na0II(9:l)中(第1
図中、一点鎖線で示す)
λmax 242±3nm(E’%=830ffilO
O)lc屑
266±3nm(E’%=648±50)lct!
300±3nm(E’%−540±50)cx
370±3nm (E”=356±50)cz
(7)光外部吸収(IR)スペクトル(添付の第2図参
照)・KBr中
下記の主な吸収を示す。TAN-876A (1) Appearance: pale yellow solid (2) Melting point, >300°C (decomposed) (3) Molecular weight measurement value + (by El-MS method) 331 (
M'') (4) Elemental analysis value (%); Actual value: C: 47.48, If: 2.83, N: 4.4
9, C &: 32.57 Calculated value・C: 46.95, H: 2.42, N・4.21
゜CI2: 31.98, O: 14.43 (5) Molecular formula: C13H8NCC303 (6) Ultraviolet absorption (UV) spectrum (see attached Figure 1) In methanol (indicated by the solid line in Figure 1) λmax 2
42 ± 3 nm (E'% - 980 ± 100) c2 298 ± 3 nm (E'% = 308 ± 50) lCj! 360±3 nm (E1%-318±50) cx Methanol: INt (in CQ(9:I) (indicated by the broken line in Figure 1) λmax 247±3 nm (E1%-1+34 soil 100
) IC shoulder 357 ± 3 nm (E'% - 332 ± 50) cx Methanol: IN Na0II (9:l) (1st
(Indicated by a dashed line in the figure) λmax 242 ± 3 nm (E'% = 830ffilO
O) lc scrap 266±3 nm (E'%=648±50) lct! 300±3nm (E'%-540±50)cx 370±3nm (E''=356±50)cz (7) Optical external absorption (IR) spectrum (see attached Figure 2)・The following main components in KBr Indicates absorption.
3.130.3210.3150.29g0.2950
.1615.1590゜+570.1530.1440
.14+0.1350.1310. +270゜125
0、1230.1170.1080.1060.102
0.980.900゜850、800.780.770
.750.710.645.620(cm−’)(8)
’H−核磁気共鳴(NMR)スペクトル=400M
Hz、ジメチルスルホキサイド−d、中下記のシグナル
が認められる。3.130.3210.3150.29g0.2950
.. 1615.1590°+570.1530.1440
.. 14+0.1350.1310. +270°125
0, 1230.1170.1080.1060.102
0.980.900°850, 800.780.770
.. 750.710.645.620 (cm-') (8)
'H-Nuclear magnetic resonance (NMR) spectrum = 400M
Hz, dimethyl sulfoxide-d, the following signals were observed.
1.17(3H,t)、2.62(2H,Q)、7.6
7(11(、s)、I 3.55(I H,s)(pp
m)(ただし、s: singled、 t: tri
plet、 q: quartetを示す)
(9)IIPLC+担体、YMC−PAK A−312
、移動相: 65%アセトニトリル10.01Mリン酸
緩衝液(pH6、3)、流速; 2xg/win。1.17 (3H, t), 2.62 (2H, Q), 7.6
7 (11 (, s), I 3.55 (I H, s) (pp
m) (s: singled, t: tri
plet, q: indicates quartet) (9) IIPLC + carrier, YMC-PAK A-312
, Mobile phase: 65% acetonitrile 10.01M phosphate buffer (pH 6,3), flow rate: 2xg/win.
検出法: UV(220nm)
Rt=2.75(IIlin、)
(10)呈色反応
陽性:過マンガン酸カリウム
陰性:バートン、酢酸マグネシウム、ドラーゲンドルフ
、ニンヒドリン、グレ
ーグ・リーバツク反応
(11)物質区分
脂溶性酸性物質
’rAN 876I3
(1) 外観:微黄色固体
(2)分子量測定値:(EIMS法による)333(M
つ
(4)元素分析値(%):
実測値:C:46.76、II:2.99、N:4.3
3、CQ:30.83
計算値: C:46.66、H:3.Ot、N:4.l
9、CQ:31.79、O:14.35
(5)分子式: C++H+oNC(!*0+(6)
UVスペクトル:(添付の第3図参照)メタノール中
(第3図中、実線で示す)λwax 308±3nm(
E’%−417±50)cx
メタノール: IN 11(J!(9:l)中(第3
図中、破線で示す)
λwax 314±3nm(E’%=591±50)1
cm
メタノール: IN Na0)[(9:1)中(第3
図中、一点鎖線で示す)
λmax 321±3nm(E1%=721±50)c
x
(7) Inスペクトル(添付の第4図参照):KB
r下記の主な吸収を示す。Detection method: UV (220 nm) Rt=2.75 (IIlin,) (10) Color reaction positive: Potassium permanganate negative: Burton, magnesium acetate, Dragendorff, ninhydrin, Greig-Lieback reaction (11) Substance classification Lipid-soluble acidic substance 'rAN 876I3 (1) Appearance: Slight yellow solid (2) Molecular weight measurement: (by EIMS method) 333 (M
(4) Elemental analysis value (%): Actual value: C: 46.76, II: 2.99, N: 4.3
3, CQ: 30.83 Calculated value: C: 46.66, H: 3. Ot, N: 4. l
9, CQ: 31.79, O: 14.35 (5) Molecular formula: C++H+oNC(!*0+(6)
UV spectrum: (see attached Figure 3) in methanol (indicated by solid line in Figure 3) λwax 308 ± 3 nm (
E'%-417±50) cx Methanol: IN 11 (J! (9:l) (3rd
(Indicated by a broken line in the figure) λwax 314 ± 3 nm (E'% = 591 ± 50) 1
cm Methanol: IN Na0) [(9:1) (3rd
In the figure, indicated by a dashed line) λmax 321±3 nm (E1%=721±50)c
x (7) In spectrum (see attached Figure 4): KB
r Shows the following main absorptions.
3500、31F10.29B0.2700.2650
.1610.1590゜+470.1420.14G0
.1330.130G、 1290.126G。3500, 31F10.29B0.2700.2650
.. 1610.1590°+470.1420.14G0
.. 1330.130G, 1290.126G.
1220、1200.1155.1080.1050.
1020.980.930゜875、850.790.
770.750.730.690.660゜620゜5
60(cm−’)
(8) ’H−NMRスペクトル: 400 MHz
、ジメチルスルホキサイド−d8中
下記のシグナルが認められる。1220, 1200.1155.1080.1050.
1020.980.930°875, 850.790.
770.750.730.690.660゜620゜5
60 (cm-') (8) 'H-NMR spectrum: 400 MHz
, the following signals were observed in dimethyl sulfoxide-d8.
1.10(311,t)、6.48(I II、 s)
、7.13(ILl、s)、8.79(11−I、s)
、9.18(lH,s)、13.2(l H,5Xpp
I11)
(9)HPLC:成分Aと同一条件下
Rt= 5 、 l (ffiin、 )(10)呈色
反応
陽性二過マンガン酸カリウム、バートン、酢酸マグネシ
ウム(黄色)反応
陰性: ドラーゲンドルフ、ニンヒドリン、グレーグ・
リーバツク反応
(11) 物質区分
脂溶性酸性物質
また、抗生物質TAN−876Aお上びBの化学構造は
下式によって示される。1.10 (311, t), 6.48 (I II, s)
, 7.13 (ILl, s), 8.79 (11-I, s)
, 9.18(lH,s), 13.2(lH,5Xpp
I11) (9) HPLC: Same conditions as component A Rt = 5, l (ffiin, ) (10) Color reaction positive Potassium dipermanganate, Burton, magnesium acetate (yellow) Reaction negative: Dragendorff, ninhydrin , Greig
Liebak reaction (11) Substance classification Lipid-soluble acidic substance The chemical structures of antibiotics TAN-876A and TAN-876B are shown by the following formula.
TAN−876A TAN−876B次
に、抗生物質TAN−876A、Bの3種微生物に対す
る抗菌活性を第1,2および3表に示す。TAN-876A TAN-876B Tables 1, 2 and 3 show the antibacterial activity of antibiotics TAN-876A and TAN-876B against three types of microorganisms.
さらに、TAN−876Aのマウスを用いた急性、1i
性は第・1表に示すとおりである。Furthermore, acute, 1i using TAN-876A mice
The characteristics are shown in Table 1.
第4表
以上の物理化学的性状および生物学的性状から明らかな
ように、’l’ A N −876AおよびBは新規抗
生物質であり、強い抗細菌および抗真菌作用を示し、咄
乳動物等に対する毒性が認められないので、医薬、動物
薬および農薬として有用な物質である。As is clear from the physicochemical and biological properties shown in Table 4 and above, 'l' AN-876A and B are new antibiotics, exhibit strong antibacterial and antifungal effects, and are effective against mammals, etc. It is a useful substance as a medicine, veterinary medicine, and agricultural chemical because it is not toxic to humans.
本抗生物質を使用するに際して、たとえばTAN−87
6またはその塩を細菌感染症に殺菌剤として用いるには
、TAN−876−またはその塩を薬理学的に許容され
得ろ担体、賦形剤、希釈剤などと混合し、たとえばTA
N−876またはその塩をTAN−876として約0.
OI〜2w/v%、好ましくは約0.1=1w/v%の
濃度でアルコールまたは水などに溶解した液剤またはt
gあたりTAN−876として約0.OF+−50mg
、好ましくは約0.5〜20mg含有する軟膏剤として
、咄乳動物(たとえば、ヒト、牛、馬、犬など)の手、
足、顔などに塗布することにより、これらの部位の殺菌
、消毒に用いることができる。When using this antibiotic, for example, TAN-87
To use TAN-876 or a salt thereof as a bactericidal agent for bacterial infections, TAN-876- or a salt thereof is mixed with a pharmacologically acceptable carrier, excipient, diluent, etc.
N-876 or its salt is about 0.0% as TAN-876.
A solution or t dissolved in alcohol or water etc. at a concentration of OI ~ 2 w/v%, preferably about 0.1=1 w/v%.
Approximately 0.0 g of TAN-876 per g. OF+-50mg
, preferably as an ointment containing about 0.5 to 20 mg, on the hands of mammalian animals (e.g., humans, cows, horses, dogs, etc.);
By applying it to the feet, face, etc., it can be used to sterilize and disinfect these areas.
以下に実施例を挙げて、本発明をさらに具体的に説明す
るが、これによって本発明が限定されるものではない。The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited thereto.
なお、培地におけるパーセント(%)は、とくにことわ
りのない限り重量/容量パーセントを表わす。Note that percentages (%) in the culture medium represent weight/volume percentages unless otherwise specified.
実施例1
酵母エキス・麦芽エキス斜面寒天培地に培養したストレ
プトミセス・ニス・ピーC−70899(IFO−14
509、FERM P−8807)を200yg容三角
フラスコ内のグルコース2%、可溶性澱粉3%、生大豆
粉1%、コーン・スチイーブ・リカー1%、ペプトン0
5%、NaCQ 03%、CaCO5,0,5%を含む
40j112の種培地(pH7,0)に接種し、28℃
、48時間回転振盪機上で培養し、前培養液を得た。得
られた前培養液の5IQ、を200Off(容坂ロフラ
スコ内の5002Qの種培地に移植し、28℃、48時
間往復振盪機上で培養し種培養液を得た。この種培養液
500TIQを50Q容ステンレススチールタンク内の
30Q種培地(l:、足踵培地と同一組成)に移植し、
通気30ρ/分、撹拌280回転/分、内圧1kg/c
tx’の条件で培養した。得られた培養液の5Qを20
0Q容ステンレススチールタンク内のグルコース05%
、デキストリン5%、脱脂大豆粉3.5%、CoCQ=
0.0002%、CaCO30,7%を含む+20Q
の主培地(pH7,0)に移植し、28℃、通気+20
Q/分、撹拌180回転/分、内圧1に9/cm’の条
件で96時間培養した。Example 1 Yeast extract/malt extract Streptomyces nis p. C-70899 (IFO-14) cultured on slanted agar medium
509, FERM P-8807) in a 200 yg Erlenmeyer flask with 2% glucose, 3% soluble starch, 1% raw soybean powder, 1% corn stew liquor, and 0 peptone.
40j112 seed medium (pH 7,0) containing 5% NaCQ, 03% NaCQ, 5% CaCO, and incubated at 28°C.
, and cultured on a rotary shaker for 48 hours to obtain a preculture solution. 5IQ of the obtained preculture solution was transferred to a 200Off (5002Q seed medium in a Yosaka Lof flask and cultured on a reciprocating shaker at 28°C for 48 hours to obtain a seed culture solution.This seed culture solution 500TIQ Transplanted into a 30Q seed medium (l:, same composition as the heel medium) in a 50Q stainless steel tank,
Ventilation 30ρ/min, stirring 280 rpm, internal pressure 1kg/c
The cells were cultured under tx' conditions. 5Q of the obtained culture solution was 20
Glucose 05% in 0Q capacity stainless steel tank
, dextrin 5%, defatted soybean flour 3.5%, CoCQ=
+20Q containing 0.0002%, CaCO30.7%
Transplanted to the main medium (pH 7,0) and kept at 28℃, aeration +20
The cells were cultured for 96 hours under the conditions of Q/min, stirring at 180 revolutions/min, and internal pressure of 1 to 9/cm'.
かくして、得られた培養液(100f2)を希硫酸てp
H4に調整し、酢酸エチル(+00Q)を加え、30分
間撹拌した。培養液と有機溶媒の混合液を濾過補助剤を
用いて濾過した。濾液(170g)の水層部分を分離除
去し、抽出*m溶媒層(85&)を水洗した。酢酸エチ
ル層(77(りを減圧上濃縮−(100g)に付し、カ
ラムをn−ヘキサンで一洗浄 −後、抗菌活性区分をク
ロロホルム(1f2)で溶出した。溶出区分を濃縮し、
再度シリカゲルクロマトグラフィー(509)に付し、
クロロホルムで溶出、TAN−876A、 Bを含む
両分を得た。両分の濃縮液をさらにシリカゲルクロマト
グラフィーに付しく50g)、トルエンおよびトルエン
とクロロホルムの混合液で溶出分画した。分画区分を分
析用11 P L Cに付し、TAN−876Aおよび
Bの含有量を調べた。主として、TAN−876Aを含
む両分を集めて濃縮するとTAN−876Aの微黄色結
品(120R9)が析出した。主として′rAN−87
6Bを含む両分を集めて濃縮し、濃縮残渣にn−ヘキサ
ンを加えて粉末(150mg)を得た。この粉末をメタ
ノールに溶解し、分取用1−I PLCに付した[担体
: YMC−PAK 0DS−S10、移動相: 55
%アセトニトリル10.01Mリン酸緩衝液(pt■6
、3 )]。分析用HP L Cで各分画中の成分含
量を調べ、TAN−876Bが水層をpl+ 3 、5
に、1.q整し、酢酸エチルで抽出、抽出液を水洗後濃
縮すると、TAN−87613の結晶性粉末(85ay
)が得られた。The thus obtained culture solution (100 f2) was diluted with dilute sulfuric acid.
The mixture was adjusted to H4, ethyl acetate (+00Q) was added, and the mixture was stirred for 30 minutes. The mixture of culture solution and organic solvent was filtered using a filter aid. The aqueous layer of the filtrate (170 g) was separated and removed, and the extracted*m solvent layer (85&) was washed with water. The ethyl acetate layer (77) was concentrated under reduced pressure (100 g), and the column was washed once with n-hexane. The antibacterial active fraction was eluted with chloroform (1f2). The eluted fraction was concentrated,
Subjected again to silica gel chromatography (509),
Elution was performed with chloroform, and both fractions containing TAN-876A and TAN-876B were obtained. Both concentrated solutions were further subjected to silica gel chromatography (50 g) and fractionated by elution with toluene and a mixture of toluene and chloroform. The fractions were subjected to analytical 11 PLC and the contents of TAN-876A and B were examined. When both fractions mainly containing TAN-876A were collected and concentrated, a slightly yellow crystal of TAN-876A (120R9) was precipitated. Mainly 'rAN-87
Both fractions containing 6B were collected and concentrated, and n-hexane was added to the concentrated residue to obtain a powder (150 mg). This powder was dissolved in methanol and subjected to preparative 1-I PLC [carrier: YMC-PAK 0DS-S10, mobile phase: 55
% acetonitrile 10.01M phosphate buffer (pt■6
, 3)]. The component content in each fraction was examined using analytical HPLC, and TAN-876B was used to analyze the aqueous layer at pl+3, 5
1. After adjusting the q and extracting with ethyl acetate, washing the extract with water and concentrating, a crystalline powder of TAN-87613 (85 ay
)was gotten.
実施例2
′1゛ΔN876A(純度的90%、150 mg)を
2%炭酸ナトリウム溶液(300m□に溶かし、微量の
不溶物を濾去した。濾液をアンバーライトXΔI)−1
1(50mののカラムクロマトグラフィーに付し、カラ
ムを水洗(400m&)後、30%メタノール−水(5
00mg)および50%メタノール−水(500mので
抗生物質を溶出、分画した。有効区分(750m&)を
集め、濃縮、凍結乾燥すると黄色粉末(125mg)が
得られた。Example 2 '1゛ΔN876A (90% purity, 150 mg) was dissolved in a 2% sodium carbonate solution (300 m□, and a trace amount of insoluble matter was removed by filtration. The filtrate was mixed with Amberlite XΔI)-1
1 (50 m), and after washing the column with water (400 m), 30% methanol-water (50 m) was applied.
The antibiotic was eluted and fractionated using 50% methanol-water (500 mg) and 50% methanol-water (500 m). The effective fraction (750 m&) was collected, concentrated, and lyophilized to yield a yellow powder (125 mg).
この粉末をメタノールに溶かし、放置すると、結晶が析
出し、濾取後、乾燥してTAN−876Aのナトリウム
塩(95+++g)が微黄色結晶として得られた。When this powder was dissolved in methanol and left to stand, crystals were precipitated, collected by filtration, and dried to obtain the sodium salt of TAN-876A (95+++ g) as slightly yellow crystals.
児索分析値(%): C+J17NC1s03・Na(
1,5+r2o)
実測値:C:40.I’l、H:2.78、N:3.8
8、C(!:26.50、Na:6.8
− *
計算値:C:4.0.92、H+2.64、N:3.6
7、(J!:27.87、O:18.87、Na:6.
02
(*:1.5モルの水分を含むとして計算)rnスペク
トル・KBr中
主な吸収
3450、3210.29g0.2940.1610.
1590.1570゜1530、1440.14+0.
1330.13IQ、 1270. +250゜122
0、11?0.1090.1060.1015.970
.900.850゜800、780.770.710.
640(am−’)融点:>300°C(分解)
発明の効果
本発明のTAN 876AおよびBはストレプトミセ
ス属菌によって生産される新規抗生物質であり、耐性菌
を含む細菌類および真菌類に有効であるので医薬、農薬
または動物薬として有用である。Child cord analysis value (%): C+J17NC1s03・Na(
1,5+r2o) Actual value: C: 40. I'l, H: 2.78, N: 3.8
8, C (!: 26.50, Na: 6.8 - * Calculated value: C: 4.0.92, H + 2.64, N: 3.6
7, (J!: 27.87, O: 18.87, Na: 6.
02 (*: Calculated assuming that it contains 1.5 mol of water) rn spectrum - Main absorption in KBr 3450, 3210.29g 0.2940.1610.
1590.1570°1530, 1440.14+0.
1330.13IQ, 1270. +250°122
0, 11? 0.1090.1060.1015.970
.. 900.850°800, 780.770.710.
640 (am-') Melting point: >300°C (decomposition) Effects of the invention TAN 876A and B of the present invention are novel antibiotics produced by Streptomyces, and are effective against bacteria and fungi including resistant bacteria. Since it is effective, it is useful as a medicine, agricultural chemical, or veterinary medicine.
第1図は本発明の新規抗生物質TAN−876への紫外
部吸収スペクトル、第2図はその赤外部吸収スペク)・
ル、第3図は’l’AN−876I3の紫外部吸収スペ
クトル、第・1図はその光外部吸収スペクトルである。Figure 1 shows the ultraviolet absorption spectrum of the novel antibiotic TAN-876 of the present invention, and Figure 2 shows its infrared absorption spectrum.
Figure 3 shows the ultraviolet absorption spectrum of 'l'AN-876I3, and Figure 1 shows its optical external absorption spectrum.
Claims (2)
R^1とR^2とでエーテル結合を示す。]で表される
抗生物質TAN−876またはその塩。(1) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R^1 represents a hydroxyl group and R^2 represents hydrogen,
R^1 and R^2 represent an ether bond. ] Antibiotic TAN-876 or a salt thereof.
76生産菌を培地に培養し、培養物中に抗生物質TAN
−876を生成蓄積せしめ、これを採取することを特徴
とする抗生物質TAN−876の製造法。(2) Antibiotic TAN-8 belonging to the genus Streptomyces
76-producing bacteria were cultured in a medium, and the antibiotic TAN was added to the culture.
A method for producing the antibiotic TAN-876, which comprises producing and accumulating TAN-876 and collecting it.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15048486 | 1986-06-25 | ||
JP61-150484 | 1986-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63152992A true JPS63152992A (en) | 1988-06-25 |
JPH0637498B2 JPH0637498B2 (en) | 1994-05-18 |
Family
ID=15497884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15678687A Expired - Lifetime JPH0637498B2 (en) | 1986-06-25 | 1987-06-24 | Antibiotic TAN-876 and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0637498B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019522048A (en) * | 2016-06-20 | 2019-08-08 | ユニバーシティ・オブ・ダンディー | Anti-infective |
-
1987
- 1987-06-24 JP JP15678687A patent/JPH0637498B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019522048A (en) * | 2016-06-20 | 2019-08-08 | ユニバーシティ・オブ・ダンディー | Anti-infective |
US11485720B2 (en) | 2016-06-20 | 2022-11-01 | University Of Dundee | Anti-infective agents |
Also Published As
Publication number | Publication date |
---|---|
JPH0637498B2 (en) | 1994-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3887820T2 (en) | Antibiotics, benanomicins A and B and dexylosylbenanomicin B, their production and use. | |
JPH0216756B2 (en) | ||
JP2802097B2 (en) | Novel anticancer antibiotic MI43-37F11 and method for producing the same | |
JPH0147479B2 (en) | ||
US4495286A (en) | Antibiotic complex producing bacterial culture | |
JPS63152992A (en) | Antibiotic substance tan-876 and production thereof | |
US4301248A (en) | Fermentation process for making rachelmycin | |
WO2000053792A1 (en) | Substances wk-5344a and wk-5344b and process for producing the same | |
JPH1045738A (en) | Antibiotic epoxyquinomycins C and D, their production and antirheumatic agents | |
JPH01246288A (en) | Tan-1030a and its derivative, production and use thereof | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
DE3782199T2 (en) | BIOLOGICALLY ACTIVE PEPTIDE TAN-866. | |
JPS6225156B2 (en) | ||
SU1395146A3 (en) | Strain of actinomycete streptomyces virginiae nrrl 15156 and 12525 - producer of antibiotic complex a 41030 and method of producing antibiotic complex a 41030 | |
JP3327982B2 (en) | New antibiotic MI481-42F4-A related substance | |
JPS5913190B2 (en) | Antibiotic C-11924F-1 | |
JPH046720B2 (en) | ||
WO1998043955A1 (en) | Tetramic acid compound | |
JPH03155793A (en) | Novel substance dc114-c | |
JPH0623192B2 (en) | Antibiotic TAN-868A and method for producing the same | |
JPS62190193A (en) | Novel platelet-agglutination suppressing substance aglyceride a, b and c, production and use thereof | |
JPS63280073A (en) | Novel antibiotic yp-02978l-c and production thereof | |
JPH0948781A (en) | Lactonamycin, a new antibiotic, and its production method | |
JPH0578308B2 (en) | ||
JPH072807A (en) | New substance allosamizoline |